AU2530795A - Assay for hiv-1 group o using at least one gp41 peptide - Google Patents

Assay for hiv-1 group o using at least one gp41 peptide

Info

Publication number
AU2530795A
AU2530795A AU25307/95A AU2530795A AU2530795A AU 2530795 A AU2530795 A AU 2530795A AU 25307/95 A AU25307/95 A AU 25307/95A AU 2530795 A AU2530795 A AU 2530795A AU 2530795 A AU2530795 A AU 2530795A
Authority
AU
Australia
Prior art keywords
hiv
peptide
assay
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25307/95A
Inventor
Richard Julian Stuart Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Murex Technologies Corp
Original Assignee
International Murex Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Murex Technologies Corp filed Critical International Murex Technologies Corp
Publication of AU2530795A publication Critical patent/AU2530795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
AU25307/95A 1994-05-19 1995-05-19 Assay for hiv-1 group o using at least one gp41 peptide Abandoned AU2530795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9410044 1994-05-19
GB9410044A GB9410044D0 (en) 1994-05-19 1994-05-19 Assay
PCT/GB1995/001146 WO1995032293A1 (en) 1994-05-19 1995-05-19 Assay for hiv-1 group o using at least one gp41 peptide

Publications (1)

Publication Number Publication Date
AU2530795A true AU2530795A (en) 1995-12-18

Family

ID=10755400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25307/95A Abandoned AU2530795A (en) 1994-05-19 1995-05-19 Assay for hiv-1 group o using at least one gp41 peptide

Country Status (4)

Country Link
AU (1) AU2530795A (en)
GB (1) GB9410044D0 (en)
WO (1) WO1995032293A1 (en)
ZA (1) ZA954126B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19622088A1 (en) * 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV antibodies as control samples
FR2775287B1 (en) * 1998-02-24 2000-11-24 Pasteur Sanofi Diagnostics CONSENSUS SYNTHETIC PEPTIDES FOR USE IN BIOLOGICAL TRIALS FOR THE DETECTION OF GROUP O HIV 1 VIRUS INFECTIONS
FR2761993B1 (en) * 1997-04-09 1999-05-21 Pasteur Sanofi Diagnostics SYNTHETIC PEPTIDES FOR USE IN BIOLOGICAL TRIALS FOR THE DETECTION OF HIV VIRUS INFECTIONS 1 GROUP 0
EP0973802B1 (en) 1997-04-09 2006-10-25 Bio-Rad Pasteur Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
EP1003878A2 (en) * 1997-07-18 2000-05-31 Innogenetics N.V. Hiv-1 group o antigens and uses thereof
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
WO2000004383A2 (en) * 1998-07-14 2000-01-27 Abbott Laboratories Hiv group o positive control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608413B2 (en) * 1988-03-30 1991-03-28 Abbott Laboratories Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
ATE120234T1 (en) * 1988-06-09 1995-04-15 Innogenetics Nv HIV-3 RETROVIRUS AND ITS USE.
BR9305435A (en) * 1992-03-06 1994-12-27 Innogenetics Nv Process for determining peptides corresponding to immunologically important epitopes and their use in a process for determining biotinylated antibodies or peptides corresponding to immunologically important epitopes, process for preparing them and compositions containing them
CA2107732C (en) * 1992-10-06 2003-04-08 Lutz G. Gurtler Retrovirus from the hiv group and its use

Also Published As

Publication number Publication date
GB9410044D0 (en) 1994-07-06
WO1995032293A1 (en) 1995-11-30
ZA954126B (en) 1996-11-19

Similar Documents

Publication Publication Date Title
AU7238296A (en) Wafer gripper
AU5446996A (en) Nitrosylated neuropeptides
AU6255096A (en) Pegylated modified proteins
AU6173798A (en) Vial gripper mechanism
AU4580096A (en) Forms stacker
AU4954596A (en) Recombinant human immunodeficiency virus-producing cell
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU4330796A (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz(b,f)oxepines
AU3900893A (en) Quantitative viral assay
AUPO026596A0 (en) Viral peptide
AU2530795A (en) Assay for hiv-1 group o using at least one gp41 peptide
AU5532396A (en) Pharmaceutical preparations derived from european mistletoe
AU6161794A (en) Peptides having anti-hiv activity
AU1373395A (en) Vpr receptor protein
AU2660400A (en) Rantes-derived peptides with anti-hiv activity
AU7514594A (en) Feline immunodeficiency virus isolate ncsu 1
AU1999999A (en) Contryphan peptides
AUPN024994A0 (en) Assay and peptides for use therein
AU5100696A (en) Specific hiv-1 group o antigens
EP1037963A4 (en) X-ray crystal comprising hiv-1 gp120
AU5522694A (en) Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof
AU2023092A (en) New hiv-1 gag and env peptides, diagnostic
AU1954995A (en) Viral replicon
AU5161296A (en) Anti-haemorrhagic peptides